| http://www.w3.org/ns/prov#value | - The 36-week, multinational, randomized, double-blind, placebo-controlled studies will include approximately 600 patients with moderate to severe HS and will be conducted at approximately 50 sites worldwide, including sites in Australia, Canada, Europe and the United States.
|
